SCHEMBL7966432

SCHEMBL7966432

Cc1ccc(S(=O)(=O)OCCC2COc3ccccc3O2)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.61
SMN1; SMN2 Q16637 1/20 0.58
CA2 P00918 5/20 0.50
RAB9A P51151 1/20 0.49
HTT P42858 1/20 0.48
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CA1 P00915 1/20 0.45
CA4 P22748 1/20 0.45
CA5A P35218 1/20 0.45
CA9 Q16790 1/20 0.45
CA5B Q9Y2D0 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MEN1 O00255 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
MTNR1A P48039 1/20 0.43
MAPT P10636 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5845241 0.87 LMNA (0.64) LMNASMN1; SMN2CA2RAB9APOLB
SCHEMBL567428 0.87 LMNA (0.64) LMNASMN1; SMN2CA2RAB9APOLB
SCHEMBL440397 0.87 LMNA (0.64) LMNASMN1; SMN2CA2RAB9APOLB
SCHEMBL17272346 0.85 LMNA (0.45) LMNASMN1; SMN2CA2RAB9APOLB
SCHEMBL11246201 0.84 CA2 (0.47) LMNASMN1; SMN2CA2RAB9ACA1
SCHEMBL1545033 0.83 CA2 (0.56) LMNASMN1; SMN2CA2HTTPOLB
SCHEMBL8425207 0.82 LMNA (0.44) LMNASMN1; SMN2CA2CA1CA9
SCHEMBL8424531 0.81 CA2 (0.54) LMNASMN1; SMN2CA2ALDH1A1TSHR
SCHEMBL8649232 0.80 LMNA (0.44) LMNASMN1; SMN2POLBCA1CA9
SCHEMBL10334247 0.80 LMNA (0.58) LMNASMN1; SMN2CA2RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313160-B1 FOR THERAPY AND PROPHYLAXIS OF MELATONINERGIC DISORDERS ADIR ET COMPAGNIE (FR) 2001-11-06 US disclosed
EP-0445026-B1 Aminomethylpiperidine derivatives, their process for preparation and the pharmaceutical compositions containing them ADIR (FR) 1994-01-26 EP disclosed
US-5229399-A Analgesics ADIR ET COMPAGNIE (FR) 1993-07-20 US disclosed
US-5229398-A Analgesics ADIR ET COMPAGNIE (FR) 1993-07-20 US disclosed
US-5192775-A Analgesics ADIR ET COMPAGNIE (FR) 1993-03-09 US disclosed
US-5112855-A Nootropic Agents CIBA-GEIGY CORPORATION (US) 1992-05-12 US disclosed
EP-0445026-A1 Aminomethylpiperidine derivatives, their process for preparation and the pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1991-09-04 EP disclosed
US-4957928-A NOOTROPIC AGENTS, COGNITION ACTIVATORS CIBA-GEIGY CORPORATION (US) 1990-09-18 US disclosed
US-4329348-A ANTIDEPRESSANTS AND PSYCHOSTIMULANTS CIBA-GEIGY CORPORATION (US) 1982-05-11 US disclosed
US-4140781-A Analgesic and neuraleptic 2-piperidinoalkyl-1,4-benzodioxans CIBA-GEIGY CORPORATION (US) 1979-02-20 US disclosed
US-4129655-A Neuroleptic 2-piperidinoalkyl-1,4-benzodioxans CIBA-GEIGY CORPORATION (US) 1978-12-12 US disclosed
US-4104396-A NEUROLEPTIC, ANALGESIC CIBA-GEIGY CORPORATION (US) 1978-08-01 US disclosed
US-4039676-A NEUROLEPTIC AGENTS CIBA-GEIGY CORPORATION (US) 1977-08-02 US disclosed